Samuel Ejadi works in the field of Oncology. He graduated from Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74/67 in Research/PrimaryCare. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Samuel Ejadi, MD has written publications. He has 3 publications published with PubMed. The lastest paper is: 'Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.' Samuel Ejadi is registered with Medicare.
NPI NUMBER | 1285605212 | |
NPPES Provider LastName | EJADI | |
NPPES Provider FirstName | SAMUEL | |
NPPES Provider ZIPCode | 852595404 | |
NPPES Provider State | AZ | |
Specialty Description | Medical Oncology | |
Total Claim Count | 84.0 | |
Distinct Opioid Count | 0.0 | |
Opioid Claim Count | 0.0 | |
Percent Opioid Claims | 0.0 |
National Provider Identifier [NPI] | 1285605212 |
Last Name Of The Provider | EJADI |
First Name Of The Provider | SAMUEL |
View All |
![]() |
Dr. Patrick J. Donovan, MD
![]() |
![]() |
Dr. Michael S. Gordon, MD
![]() |
![]() |
Dr. Philip J. Federio, MD |
![]() |
Dr. Michael S. Roberts, MD |
![]() |
Dr. Mitesh J. Borad, MD
![]() ![]() |
![]() |
Dr. Alan H. Bryce, MD
![]() ![]() |
![]() |
Dr. Donald W. Northfelt, MD
![]() ![]() |
![]() |
Dr. Harshita R. Paripati, MD
![]() |